| ²é¿´: 635 | »Ø¸´: 2 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
snowinheartÒø³æ (ÕýʽдÊÖ)
|
[½»Á÷]
ÇóÖúÒ»¶ÎÒ©´úѧµÄÖÐÒëÓ¢
|
||
| °ÐÏòÒ©ÎïµÄÒ©´ú¶¯Á¦Ñ§Ñо¿ÊÇ·ÇÁÙ´²Ò©´ú¶¯Á¦Ñ§£¬Ñо¿µÄÄ¿µÄÊǽÒʾ°ÐÏòÒ©ÎïÔÚ¶¯ÎïÌåÄڵĶ¯Ì¬±ä»¯¹æÂÉ£¬²ûÃ÷Ò©ÎïµÄÎüÊÕ¡¢·Ö²¼¡¢´úлºÍÅÅйµÄ¹ý³ÌºÍÌØµã£¬²¢¸ù¾ÝÄ£ÐÍÌá¹©ÖØÒªµÄÒ©´ú¶¯Á¦Ñ§²ÎÊý£¬ÎªÒ©Ð§Ñ§ºÍ¶¾ÀíѧÆÀ¼ÛÌṩÁËÒ©Îï»ò»îÐÔ´úлÎïŨ¶ÈÊý¾Ý£¬²¢ÎªÉè¼ÆºÍÓÅ»¯ÁÙ´²Ñо¿¸øÒ©·½°¸ÌṩÓйØÒÀ¾Ý¡£·ÇÁÙ´²Ò©´ú¶¯Á¦Ñ§Ñо¿Öе͝ÎïÓÐ×ÅÌØ¶¨µÄÒªÇ󣬴´ÐÂҩӦѡÓÃÁ½ÖÖ»òÁ½ÖÖÒÔÉϵ͝ÎÆäÖÐÒ»ÖÖΪÄö³ÝÀදÎÁíÒ»ÖÖΪ·ÇÄö³ÝÀදÎï¡£ÆäËûÀàÐ͵ÄÒ©Î¿ÉÑ¡ÓÃÒ»ÖÖ¶¯ÎÊ×Ñ¡·ÇÄö³ÝÀදÎÈçÍûòºïµÈ£©¡£ÓÉÓÚ°ÐÏòÒ©ÎïÖÐҩЧ³É·ÖÖ÷ÒªÊÇÁòËáÇì´óÃ¹ËØ£¬°ÐÏòÖÆ¼ÁÖ»ÊÇÒ»ÖÖмÁÐÍ£¬Òò´Ë±¾Ñо¿Ö»Ñ¡ÓüÒÍýøÐÐÁËÒ©´ú¶¯Á¦Ñ§ÊÔÑé¡£ÔÚÆäËû¶¯ÎïÌåÄÚ¸ÃÒ©µÄÎüÊÕ¡¢·Ö²¼¡¢´úлºÍÅÅйµÄ¹ý³ÌµÄÏà¹ØÊýÖµ¿ÉÄÜÓвîÒ죬µ«Ò©ÎïÔÚ¶¯ÎïÌåÄڵĶ¯Ì¬±ä»¯¹æÂÉÓ¦ÓëÔÚ¼ÒÍÃÌåÄÚÒ»Ö¡£ |
» ²ÂÄãϲ»¶
085600²ÄÁÏÓ뻯¹¤301·ÖÇóµ÷¼ÁԺУ
ÒѾÓÐ5È˻ظ´
081700£¬311£¬Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤085600 310·ÖÇóµ÷¼Á
ÒѾÓÐ18È˻ظ´
²ÄÁÏÓ뻯¹¤371Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
336²ÄÁÏÓ뻯¹¤085600Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
²ÄÁÏ334Çóµ÷¼Á
ÒѾÓÐ18È˻ظ´
331Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
332Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
Ò»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ ²ÄÁÏÓ뻯¹¤329·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁÏר˶322
ÒѾÓÐ7È˻ظ´
pharmjackie
ľ³æ (ÕýʽдÊÖ)
- ·ÒëEPI: 21
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 2210
- Ìû×Ó: 312
- ÔÚÏß: 180.4Сʱ
- ³æºÅ: 302356
- ×¢²á: 2006-12-02
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
snowinheart(½ð±Ò+20, ·ÒëEPI+1): 2010-05-23 16:32:19
| the pharmacokinetics of targeted drugs is non-clinnical with the main purpose to unveil the dynamic changes of targeted drugs in vivo, to elucidate the course and characteristic of the absorption, distribution, metabolization and excretion of drugs, to provide concentration data of drugs or active metabolites for pharmacological and toxicological evaluation on the base of the pharmacokinetic parameters obtained from models and to provide support to rational design and optimization of clinical regime. Special requisition is laid down in non-clinical pharmacokinetics for animals. ÔÝʱÒëÒ»¶Î£¬ÓÐʱ¼äÔÙÒë¡£ |
2Â¥2010-05-21 23:22:15
pharmjackie
ľ³æ (ÕýʽдÊÖ)
- ·ÒëEPI: 21
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 2210
- Ìû×Ó: 312
- ÔÚÏß: 180.4Сʱ
- ³æºÅ: 302356
- ×¢²á: 2006-12-02
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
snowinheart(½ð±Ò+30): 2010-05-24 18:33:59
| ´´ÐÂҩӦѡÓÃÁ½ÖÖ»òÁ½ÖÖÒÔÉϵ͝ÎÆäÖÐÒ»ÖÖΪÄö³ÝÀදÎÁíÒ»ÖÖΪ·ÇÄö³ÝÀදÎï¡£ÆäËûÀàÐ͵ÄÒ©Î¿ÉÑ¡ÓÃÒ»ÖÖ¶¯ÎÊ×Ñ¡·ÇÄö³ÝÀදÎÈçÍûòºïµÈ£©¡£ÓÉÓÚ°ÐÏòÒ©ÎïÖÐҩЧ³É·ÖÖ÷ÒªÊÇÁòËáÇì´óÃ¹ËØ£¬°ÐÏòÖÆ¼ÁÖ»ÊÇÒ»ÖÖмÁÐÍ£¬Òò´Ë±¾Ñо¿Ö»Ñ¡ÓüÒÍýøÐÐÁËÒ©´ú¶¯Á¦Ñ§ÊÔÑé¡£ÔÚÆäËû¶¯ÎïÌåÄÚ¸ÃÒ©µÄÎüÊÕ¡¢·Ö²¼¡¢´úлºÍÅÅйµÄ¹ý³ÌµÄÏà¹ØÊýÖµ¿ÉÄÜÓвîÒ죬µ«Ò©ÎïÔÚ¶¯ÎïÌåÄڵĶ¯Ì¬±ä»¯¹æÂÉÓ¦ÓëÔÚ¼ÒÍÃÌåÄÚÒ»Ö¡£ two types of animals or above are required for innovative drugs with one type being rodents and another type non-rodents, while for other drugs, one type of animals, non-rodents are prefered, such as rabbits or monkeys. rabbit is chosen for the present pharmacokinetic study for the reason that the tested targeted preparation is a new formulation contains mainly Gentamycin Sulfate. ADME related values may vary with different animals, but dynamic change law should be consistent with those obtained with rabbit. |
3Â¥2010-05-24 14:06:44














»Ø¸´´ËÂ¥